Elections in red states may be hard, but they serve as potential laboratories for Democrats to retool their struggles with working-class appeals.

Let’s stop pretending that rules forbidding coordination between campaigns and dark money groups exist.

The Big Pharma–friendly congressman from Oregon’s 5th district is lagging Jamie McLeod-Skinner in Tuesday’s primary results. How big a bellwether is it for the left?

Kurt Schrader helped bury prescription drug reform. And now he seems to have a tough primary next Tuesday.

Democratic moderates are saying that discouraging news from Washington’s fiscal referees may not be a deal-breaker.

The congressman leading the fight to kill his party’s prescription drug proposal has been taking checks from pharmaceutical interests this whole time.